June 6th, 2007

A Niche Strategy Now Under Stress

By Lousie Story
The New York Times

Could a widely praised approach to drug marketing now be at risk of backfiring? That is a question confronting GlaxoSmithKline and its diabetes treatment Avandia, which is now clouded by concerns over the drug’s safety.

Read the full article here.

Comments

Add your own Comment

(optional)